Project description
Imaging technology for assessment of patient immune status
Immunotherapy can effectively treat a number of serious conditions such as cancer and inflammatory diseases but a personalised approach is key. Blood and tissue markers coupled with non-invasive imaging could aid in assessing immune status in vivo, but this option has barely been explored. To this end, the EU-funded project will develop new immunotracers for imaging specific immune cell subsets, and then validate them in relevant disease models. The goal is to transfer them to manufacturing and then conduct smart clinical trials. This international multi-disciplinary consortium will work on optimising molecular imaging techniques for assessing patient immune status via immunotracers and developing personalised immunotherapeutic drugs.
Field of science
- /medical and health sciences/basic medicine/immunology/immunotherapy
- /medical and health sciences/health sciences/inflammatory diseases
Call for proposal
H2020-JTI-IMI2-2018-14-two-stage
See other projects for this call
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
1081 HV Amsterdam
Netherlands
Participants (22)
72074 Tuebingen
CB2 1TN Cambridge
48149 Muenster
1050 Brussel
9052 Zwijnaarde - Gent
9713 GZ Groningen
08035 Barcelona
08035 Barcelona
75015 Paris 15
431 83 Molndal
3521 AL Utrecht
3584 BL Utrecht
1016 XX Amsterdam
1000 Bruxelles
4070 Basel
51373 Leverkusen
2340 Beerse
4056 Basel
CT13 9NJ Sandwich
90301 Inglewood Ca
Participation ended
WC2B 4AE London
8152 Glattpark